share_log

公告精选 | 石药集团拟回购最多50亿港元股份;阳光保险:阳光人寿1-8月保费收入663.84亿元

Announcement Selection | cspc pharma plans to repurchase up to 5 billion Hong Kong dollars of shares; Sun Insurance: Sunshine Life Insurance premium income from January to August is 66.384 billion yuan

Futu News ·  Sep 20 08:20

The following are important announcements for today's Hong Kong stocks:

1) Company News

$ZHENRO PPT (06158.HK)$The final deadline for the restructuring support agreement has been further extended.

$CHINA CRSC (03969.HK)$From July to August, six important projects were successfully bid in the rail transit market, with a total bid amount of approximately 2.9 billion yuan, accounting for about 7.84% of the audited revenue in 2023.

$GOLDENSOLAR (01121.HK)$Attached to JN Energy and Longji, a joint venture agreement is signed to establish a joint venture company to produce HBC solar cells.

$OCUMENSION-B (01477.HK)$The new drug OT-1001 has been approved for market registration by the National Medical Products Administration.

$CH BIOTECH SER (08037.HK)$Intending to collaborate with the Jinshazhou Hospital of Guangzhou University of Traditional Chinese Medicine on the treatment of boron neutron capture, pharmaceutical and medical device referral, equity cooperation, and expansion of indications.

$FUSEN PHARM (01652.HK)$The clinical trial application for the innovative Chinese medicine drug "SY617" in category 1 has been approved.

$XINHUA WINSHARE (00811.HK)$Signed a 1.256 billion yuan procurement contract to become the sole supplier of textbooks for compulsory education stage students in Sichuan Province.

$TRANSMIT ENT (01326.HK)$Profit warning: It is expected that the annual net loss attributable to owners of the company will be approximately 0.34 billion to 0.37 billion Hong Kong dollars.

$SUNSHINE INS (06963.HK)$: Sunshine Life Insurance received premium income of 66.384 billion yuan from January to August.

2) Shareholding

$MAANSHAN IRON (00323.HK)$: Maanshan Iron Group first increased its holding of the company's A shares by 5.187 million shares

$C-MER MEDICAL (03309.HK)$Chairman and CEO Lin Shunchao increased his shareholding by a total of 1.174 million shares.

3) Buyback Dynamics

$CSPC PHARMA (01093.HK)$Proposed to further repurchase up to 5 billion Hong Kong dollars of the company's shares.

$TENCENT (00700.HK)$Spent 1.002 billion Hong Kong dollars to repurchase 2.6 million shares.

$MEITUAN-W (03690.HK)$Spent approximately 0.221 billion Hong Kong dollars to repurchase 1.706 million shares.

$AIA (01299.HK)$Invested approximately 62.0248 million Hong Kong dollars to repurchase 1.1096 million shares

$SINOPEC CORP (00386.HK)$Invested 0.115 billion Hong Kong dollars to repurchase 26 million shares

$BABA-W (09988.HK)$Invested approximately 59.9772 million US dollars to repurchase 5.6776 million shares

$PRU (02378.HK)$In the past two days, a total of approximately 19.857 million pounds was spent to repurchase around 3.1506 million shares

Editor/Emily

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment